Graphene and GBNs offer diverse PD management modalities by targeting neurodegeneration, exerting regenerative properties and their use as carriers, biosensors, and imaging agents.
8 May 2026 in Science and Technology of Advanced Materials
Among neurodegenerative diseases, synucleinopathies appear to be attractive targets for nanomaterial-based interventions due to their hallmark pathology – the misfolding and aggregation of α-synucl...
Graphene oxide functionalized with selenium (GO-Se) has emerged as a promising nanomaterial due to selenium's antioxidant and redox-regulating properties, yet its safety profile remains unclear. The present study systematically investigated the cytotoxic, oxidative, and developmental effects of GO-Se using normal human dermal fibroblasts (NHDF) cells, zebrafish embryos and complementary density functional theory (DFT) calculations. GO-Se induced a dose- and time-dependent reduction in NHDF cell viability (IC50 = 274.6 μg mL−1 at 24 h), associated with oxidative stress modulation and apoptosis. Zebrafish models revealed concentration-dependent cardiac dysfunction, developmental abnormalities, and increased reactive oxygen species (ROS) levels at ≥100 μg mL−1. DFT analyses supported these findings by showing strong electron-accepting properties of GO-Se. Overall, the study highlights both the biomedical potential and the safety concerns of GO-Se, underlining the need for further investigations into its applicability.